Business ❯ Pharmaceutical Industry ❯ Biotechnology

Drug Development

Clinical Research FDA Approval Investor Relations T Cell Engager Market Market Competition Innovative Therapies Clinical Applications Obesity Drug Trials Market Trends

FDA Approves Rusfertide (Mimrylo) for Polycythemia Vera

A once-weekly hepcidin-mimetic reducing phlebotomy need with safety concerns including anemia and thrombotic events.

Zealand Plunges as Roche Obesity Drug Posts 10.7% Weight Loss With Placebo‑Like Tolerability

New aTyr Class Action Expands Investor Window After EFZO-FIT Failure

Pumitamig Shows High Response in First-Line Small Cell Lung Cancer Phase 2